Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient – HealthLeaders Media
HealthLeaders Media |
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
HealthLeaders Media Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August. But the total costs of Kymriah and the … |
